Fine particulate matter and cardiovascular disease

被引:33
|
作者
Neas, LM [1 ]
机构
[1] US EPA, Epidemiol & Biomarkers Branch, Human Studies Div, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA
关键词
particulate matter; cardiovascular disease; co-pollutants;
D O I
10.1016/S0378-3820(99)00076-4
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
The 1996 EPA Air Quality Criteria for Particulate Matter relied in large part upon epidemiologic studies of the short-term (acute) effects of inhalable particulate matter (PM) exposures on all-cause mortality and hospitalizations with very limited experimental evidence from toxicology or clinical studies. Recent research has identified several plausible biological mechanisms for both the initial pulmonary injury and the consequent systemic effects. Current epidemiologic research interests include the component(s) of PM which are responsible for the initial pulmonary injury, the effects of co-pollutants such as ozone, and the pathophysiological mechanisms for PM-induced acute health effects. Published by Elsevier Science B.V.
引用
收藏
页码:55 / 67
页数:13
相关论文
共 50 条
  • [21] How is cardiovascular disease mortality risk affected by duration and intensity of fine particulate matter exposure? An integration of the epidemiologic evidence
    C. Arden Pope
    Robert D. Brook
    Richard T. Burnett
    Douglas W. Dockery
    [J]. Air Quality, Atmosphere & Health, 2011, 4 : 5 - 14
  • [22] How is cardiovascular disease mortality risk affected by duration and intensity of fine particulate matter exposure? An integration of the epidemiologic evidence
    Pope, C. Arden, III
    Brook, Robert D.
    Burnett, Richard T.
    Dockery, Douglas W.
    [J]. AIR QUALITY ATMOSPHERE AND HEALTH, 2011, 4 (01): : 5 - 14
  • [23] Fine particulate matter components and interstitial lung disease in rheumatoid arthritis
    Zhao, Naizhuo
    Al-Aly, Ziyad
    Zheng, Boyang
    van Donkelaar, Aaron
    Martin, Randall V.
    Pineau, Christian A.
    Bernatsky, Sasha
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60 (01)
  • [24] Fine particulate matter components and interstitial lung disease in rheumatoid arthritis
    Zhao, Naizhuo
    Al-Aly, Ziyad
    Zheng, Boyang
    van Donkelaar, Aaron
    Martin, Randall V.
    Pineau, Christian A.
    Bernatsky, Sasha
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60 (03)
  • [25] Burden of disease attributable to ambient fine particulate matter exposure in Taiwan
    Lo, Wei-Cheng
    Shie, Ruei-Hao
    Chan, Chang-Chuan
    Lin, Hsien-Ho
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2017, 116 (01) : 32 - 40
  • [26] Fine Particulate Matter and Parkinson Disease Risk Among Medicare Beneficiaries
    Krzyzanowski, Brittany
    Nielsen, Susan Searles
    Turner, Jay R.
    Racette, Brad A.
    [J]. NEUROLOGY, 2023, 101 (21) : E2058 - E2067
  • [27] Disease assimilation: The mortality impacts of fine particulate matter on immigrants to Canada
    Erickson, Anders C.
    Christidis, Tanya
    Pappin, Amanda
    Brook, Jeffrey R.
    Crouse, Daniel L.
    Hystad, Perry
    Li, Chi
    Martin, Randall, V
    Meng, Jun
    Pinault, Lauren
    van Donkelaar, Aaron
    Weichenthal, Scott
    Tjepkema, Michael
    Burnett, Richard T.
    Brauer, Michael
    [J]. HEALTH REPORTS, 2020, 31 (03) : 14 - 26
  • [28] Fine particulate matter and incident coronary heart disease in the REGARDS cohort
    Loop, Matthew Shane
    McClure, Leslie A.
    Levitan, Emily B.
    Al-Hamdan, Mohammad Z.
    Crosson, William L.
    Safford, Monika M.
    [J]. AMERICAN HEART JOURNAL, 2018, 197 : 94 - 102
  • [29] Fine Particulate Matter (PM2.5) and Chronic Kidney Disease
    Zhang, Yilin
    Liu, Dongwei
    Liu, Zhangsuo
    [J]. REVIEWS OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY, VOL 254, 2021, 254 : 183 - 215
  • [30] Ambient fine particulate matter exposure and cardiovascular mortality in China: a prospective cohort study
    Yin, Peng
    Brauer, Michael
    Cohen, Aaron
    Burnett, Richard T.
    Liu, Jiangmei
    Liu, Yunning
    Zhou, Maigeng
    [J]. LANCET, 2015, 386 : 6 - 6